ASXL2 and Pancytopenia: Of note, a fraction of the recipient mice received Asxl2+/− or Asxl2−/− BM cells developed the MDS-like disease as evidenced by dysplastic features of myeloid lineages, pancytopenia and myeloid infiltration in the spleen and liver (Supplementary Figs 7e and 8a,b, and Supplementary Table 3).